cetylpyridinium chloride anhydrous has been researched along with Coats Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auyeung, VPW; Bahlo, M; Biggs, EK; Bonelli, R; Burgess, S; Butterworth, AS; Danesh, J; Fauman, E; Forouhi, NG; Gribble, FM; Griffin, JL; Imamura, F; Kastenmüller, G; Khaw, KT; Koulman, A; Langenberg, C; Li, C; Lotta, LA; Luan, J; Michelotti, GA; Oliver-Williams, C; Paige, E; Pietzner, M; Raffler, J; Reimann, F; Sanderson, E; Scott, RA; Stewart, ID; Surendran, P; Wareham, NJ; Wheeler, E; Wittemans, LBL; Wood, AM; Zuber, V | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Coats Disease
| Article | Year |
|---|---|
A cross-platform approach identifies genetic regulators of human metabolism and health.
Topics: Diabetes Mellitus, Type 2; Eye Diseases; Gene Frequency; Genetic Loci; Genetic Pleiotropy; Genome, Human; Glucagon-Like Peptide-2 Receptor; Glycine; Health; Humans; Linear Models; Mendelian Randomization Analysis; Metabolism; Metabolism, Inborn Errors; Metabolome; Mutation, Missense; Phenotype; Polymorphism, Single Nucleotide; Retinal Telangiectasis; Sample Size; Serine | 2021 |